|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Prepaid insurance | |||||||||
| Total current assets | |||||||||
| Cash and marketable securities held in Trust Account | |||||||||
| Long-term prepaid insurance | |||||||||
| Marketable securities held in Trust Account | |||||||||
| Total Assets | |||||||||
| Current liabilities | |||||||||
| Accrued expenses | |||||||||
| Accrued offering costs | |||||||||
| Due to shareholders | |||||||||
| Promissory note - related party | |||||||||
| Total current liabilities | |||||||||
| Deferred legal fees | |||||||||
| Deferred Fee payable | |||||||||
| Total Liabilities | |||||||||
| Class A Ordinary Shares subject to possible redemption, 18,496,164 and 23,000,000 shares at redemption value of $10.89 and $10.70 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders’ Deficit | |||||||||
| Ordinary shares value | |||||||||
| Class A Ordinary Shares | |||||||||
| Class B Ordinary Shares | |||||||||
| Accumulated deficit | |||||||||
| Total Shareholders’ Deficit | |||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
